These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 20136383

  • 1. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
    Koo MS, Kim EJ, Roh D, Kim CH.
    Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383
    [Abstract] [Full Text] [Related]

  • 2. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 3. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
    Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():36-43; discussion 55-8. PubMed ID: 2199433
    [Abstract] [Full Text] [Related]

  • 4. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ, Goodman WK, Leckman JF, Price LH.
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [Abstract] [Full Text] [Related]

  • 5. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 8. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD, Fox SH.
    Prog Brain Res; 2008 Apr; 172():495-513. PubMed ID: 18772048
    [Abstract] [Full Text] [Related]

  • 9. [New approach to obsessive-compulsive disorder: dopaminergic theories].
    Harsányi A, Csigó K, Demeter G, Németh A.
    Psychiatr Hung; 2007 Apr; 22(4):248-58. PubMed ID: 18167420
    [Abstract] [Full Text] [Related]

  • 10. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 11. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone response to apomorphine in obsessive-compulsive disorder.
    Pitchot W, Hansenne M, Moreno AG, Ansseau M.
    J Psychiatry Neurosci; 1996 Nov; 21(5):343-5. PubMed ID: 8973055
    [Abstract] [Full Text] [Related]

  • 13. [Brain changes in obsessive-compulsive disorder with behavior therapy and pharmacotherapy].
    Nakao T.
    Seishin Shinkeigaku Zasshi; 2011 Nov; 113(1):60-7. PubMed ID: 21404633
    [Abstract] [Full Text] [Related]

  • 14. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis].
    Okamoto Y.
    Seishin Shinkeigaku Zasshi; 2011 Apr; 113(1):36-44. PubMed ID: 21404630
    [Abstract] [Full Text] [Related]

  • 16. [Advances of neuroimaging research and the development of pathophysiology hypothesis for obsessive-compulsive disorder].
    Matsumoto R, Nakamae T, Ito H, Takahashi H, Fukui K, Suhara T.
    Seishin Shinkeigaku Zasshi; 2011 Apr; 113(1):45-53. PubMed ID: 21404631
    [Abstract] [Full Text] [Related]

  • 17. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.
    Goddard AW, Shekhar A, Whiteman AF, McDougle CJ.
    Drug Discov Today; 2008 Apr; 13(7-8):325-32. PubMed ID: 18405845
    [Abstract] [Full Text] [Related]

  • 18. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.